Sandoz Egypt, is an affiliate of Sandoz Global, the global leader in generic and biosimilar medicines. Our purpose is pioneering access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. The treatments developed by Sandoz serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics (mainly oral solids) and complex generics (including injectables, respiratory and others) - and Biosimilars, where we are the global pioneer, with eight marketed medicines and a rapidly growing pipeline now counting 24 molecules. Community guidelines See our community guidelines: https://www.novartis.com/guidelines/novartis-linkedin-community-guidelines
